Olanrewaju O Okusanya Selected Research

Levofloxacin (Levaquin)

5/2008

Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olanrewaju O Okusanya Research Topics

Disease

12	Infections 01/2022 - 09/2009
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
2	Cystic Fibrosis (Mucoviscidosis) 09/2014 - 09/2009
1	Disease Progression 11/2022
1	Toxic Optic Neuropathy 11/2022
1	Multiple Myeloma 11/2022
1	Asthenia 01/2022
1	Cough 01/2022
1	Diarrhea 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Edema (Dropsy) 01/2022
1	Headache (Headaches) 01/2022
1	Hemorrhage 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Nausea 01/2022
1	Pancreatitis 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Musculoskeletal Pain 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Bacterial Pneumonia 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 12/2015
1	Body Weight (Weight, Body) 03/2012
1	Pseudomonas Infections 09/2009
1	Maxillary Sinusitis 05/2008

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 05/2008
3	Tazobactam FDA LinkGeneric 04/2016 - 06/2013
2	Amikacin (A.M.K)FDA LinkGeneric 09/2014 - 09/2009
2	ceftolozaneIBA 12/2013 - 06/2013
2	Fusidic Acid (Fucithalmic)IBA 06/2011 - 05/2011
1	Proteasome InhibitorsIBA 11/2022
1	Monoclonal AntibodiesIBA 11/2022
1	belantamab mafodotinIBA 11/2022
1	ponatinibIBA 01/2022
1	cedazuridineIBA 01/2022
1	decitabine and cedazuridine drug combinationIBA 01/2022
1	Decitabine FDA Link 01/2022
1	Cytidine DeaminaseIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	TabletsIBA 01/2022
1	TransferasesIBA 01/2022
1	selinexorIBA 10/2021
1	gilteritinibIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	solithromycinIBA 01/2019
1	Anti-Infective Agents (Microbicides)IBA 01/2019
1	Piperacillin FDA LinkGeneric 04/2016
1	Fosfomycin FDA Link 12/2015
1	SaltsIBA 12/2015
1	SolutionsIBA 12/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2015
1	Tromethamine (Trometamol)FDA Link 12/2015
1	tazobactam drug combination ceftolozaneIBA 09/2013
1	cefilavancinIBA 03/2012
1	Levofloxacin (Levaquin)FDA Link 05/2008

Therapy/Procedure

2	Therapeutics 11/2022 - 10/2021
1	Drug Tapering 10/2021